Russell Investments Group
MAZE

Russell Investments Group’s Maze Therapeutics MAZE Stock Holding History

Russell Investments Group’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Sell
14,508
-18,018
-55% -$472K ﹤0.01% 2848
2026
Q1 		$971K Buy
32,526
+9,981
+44% +$440K ﹤0.01% 2228
2025
Q4 		$934K Buy
22,545
+20,638
+1,082% +$709K ﹤0.01% 2246
2025
Q3 		$49.4K Buy
1,907
+1,725
+948% +$29.1K ﹤0.01% 3295
2025
Q2 		$2.23K Buy
+182
New +$1.89K ﹤0.01% 3580

Other funds holding MAZE

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MGB
Mass General Brigham Somerville, Massachusetts $361M AUM
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Russell Investments Group's MAZE Position: Q2 2026 in Review

Russell Investments Group reduced its Maze Therapeutics (MAZE) stake by 55% in Q2 2026, selling an estimated $472K and leaving 14,508 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

Russell Investments Group first reported a position in MAZE in Q2 2025 and has held it in 5 quarters since. The position peaked at $971K in Q1 2026. 46 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Russell Investments Group held 14,508 shares of Maze Therapeutics worth $433K as of Q2 2026.
  • Russell Investments Group sold 18,018 Maze Therapeutics shares in Q2 2026, an estimated $472K.
  • Maze Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2848 holding.
  • Russell Investments Group first reported a position in Maze Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Russell Investments Group's Maze Therapeutics position peaked at $971K in Q1 2026.
  • 46 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.